These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 11097365

  • 21. Rabbit atherosclerotic lesions express scavenger receptor AIII mRNA, a naturally occurring splice variant that encodes a non-functional, dominant negative form of the macrophage scavenger receptor.
    Hiltunen TP, Gough PJ, Greaves DR, Gordon S, Ylä-Herttuala S.
    Atherosclerosis; 2001 Feb 01; 154(2):415-9. PubMed ID: 11166774
    [Abstract] [Full Text] [Related]

  • 22. Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation.
    de Boer OJ, Hirsch F, van der Wal AC, van der Loos CM, Das PK, Becker AE.
    Atherosclerosis; 1997 Sep 01; 133(2):227-34. PubMed ID: 9298683
    [Abstract] [Full Text] [Related]

  • 23. Expression of lipoprotein receptors in atherosclerotic lesions.
    Hiltunen TP, Ylä-Herttuala S.
    Atherosclerosis; 1998 Apr 01; 137 Suppl():S81-8. PubMed ID: 9694546
    [Abstract] [Full Text] [Related]

  • 24. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines.
    Li H, Freeman MW, Libby P.
    J Clin Invest; 1995 Jan 01; 95(1):122-33. PubMed ID: 7814605
    [Abstract] [Full Text] [Related]

  • 25. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions.
    Hirano K, Yamashita S, Nakagawa Y, Ohya T, Matsuura F, Tsukamoto K, Okamoto Y, Matsuyama A, Matsumoto K, Miyagawa J, Matsuzawa Y.
    Circ Res; 1999 Jul 09; 85(1):108-16. PubMed ID: 10400916
    [Abstract] [Full Text] [Related]

  • 26. Localization of CD36 and scavenger receptor class A in human coronary arteries--a possible difference in the contribution of both receptors to plaque formation.
    Nakagawa-Toyama Y, Yamashita S, Miyagawa J, Nishida M, Nozaki S, Nagaretani H, Sakai N, Hiraoka H, Yamamori K, Yamane T, Hirano K, Matsuzawa Y.
    Atherosclerosis; 2001 Jun 09; 156(2):297-305. PubMed ID: 11395025
    [Abstract] [Full Text] [Related]

  • 27. Scavenger receptors and oxidized low density lipoproteins.
    Dhaliwal BS, Steinbrecher UP.
    Clin Chim Acta; 1999 Aug 09; 286(1-2):191-205. PubMed ID: 10511292
    [Abstract] [Full Text] [Related]

  • 28. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages.
    Geng YJ, Hansson GK.
    J Clin Invest; 1992 Apr 09; 89(4):1322-30. PubMed ID: 1556191
    [Abstract] [Full Text] [Related]

  • 29. Evidence that human Fc gamma receptor IIA (CD32) subtypes are not receptors for oxidized LDL.
    Morganelli PM, Groveman DS, Pfeiffer JR.
    Arterioscler Thromb Vasc Biol; 1997 Nov 09; 17(11):3248-54. PubMed ID: 9409319
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.
    Schönbeck U, Gerdes N, Varo N, Reynolds RS, Horton DB, Bavendiek U, Robbie L, Ganz P, Kinlay S, Libby P.
    Circulation; 2002 Dec 03; 106(23):2888-93. PubMed ID: 12460867
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions.
    Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa I, Kanamori H, Aburatani H, Takaku F, Suzuki H.
    Proc Natl Acad Sci U S A; 1990 Dec 03; 87(23):9133-7. PubMed ID: 2251254
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.
    Sakata N, Imanaga Y, Meng J, Tachikawa Y, Takebayashi S, Nagai R, Horiuchi S, Itabe H, Takano T.
    Atherosclerosis; 1998 Nov 03; 141(1):61-75. PubMed ID: 9863539
    [Abstract] [Full Text] [Related]

  • 37. Expression of lipoprotein receptors and related molecules in atherosclerotic lesions.
    Ylä-Herttuala S.
    Curr Opin Lipidol; 1996 Oct 03; 7(5):292-7. PubMed ID: 8937519
    [Abstract] [Full Text] [Related]

  • 38. CD40-CD40L interactions in atherosclerosis.
    Lutgens E, Daemen MJ.
    Trends Cardiovasc Med; 2002 Jan 03; 12(1):27-32. PubMed ID: 11796241
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.